Johnson and Johnson vaccine has made up a relatively small portion of Yakima County’s COVID vaccine supply, and distribution of Moderna and Pfizer vaccines will continue here uninterrupted.

Washington state immediately halted the use of the one-dose Johnson & Johnson vaccine Tuesday morning, following federal guidance. The pause came after six women who had received it developed a rare condition involving blood clots.

Washington officials aren’t aware of any instances of blood clots associated with the Johnson & Johnson vaccines here, according to Gov. Jay Inslee’s office.

The Johnson & Johnson vaccine has only been distributed by Yakima County providers for a handful of weeks. This week, Yakima County received 1,000 doses of the Johnson & Johnson vaccine, about 15.1% of the 6,640 doses received, according to Yakima Health District figures.

In total, Yakima County has received 7,900 Johnson & Johnson vaccine doses over just four weeks, according to figures provided by the Yakima Health District. In comparison, the county has been receiving many times more Pfizer and Moderna over 18 weeks.

As of late last week, five providers gave out just 1,025 Johnson & Johnson doses, according to the Yakima Health District’s vaccine report. That’s a small percentage of more than 58,000 first or single vaccine doses distributed in Yakima County.

The number of Johnson and Johnson doses given may be higher as the Yakima Health District vaccine report indicates several providers have not provided updated information.

For those who got the vaccine more than a month ago, the risk of complications is very low, the state Department of Health said.

People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider, the agency said.